{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:48:41Z","timestamp":1785912521913,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["20230622"],"award-info":[{"award-number":["20230622"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471989"],"award-info":[{"award-number":["82471989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302223"],"award-info":[{"award-number":["82302223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124399","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:14:50Z","timestamp":1782108890000},"page":"124399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synergistic \u201ctargeting and blockade\u201d strategy via engineered exosomes and clinical ultrasound contrast agent for hepatocyte-targeted mRNA delivery"],"prefix":"10.1016","volume":"335","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-8306","authenticated-orcid":false,"given":"Zhelong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6022-2804","authenticated-orcid":false,"given":"Chuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biomaterials.2026.124399_bib1","first-page":"850","volume":"4","author":"Santos","year":"2016","journal-title":"Diabet. Endocrinol."},{"issue":"10326","key":"10.1016\/j.biomaterials.2026.124399_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Familial Hypercholesterolaemia International Clinical, worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124399_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1469-1809.2012.00724.x","article-title":"Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment","volume":"76","author":"Usifo","year":"2012","journal-title":"Ann. Hum. Genet."},{"issue":"9965","key":"10.1016\/j.biomaterials.2026.124399_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124399_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jacc.2017.06.058","article-title":"Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations","volume":"70","author":"Stein","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124399_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13023-021-01999-8","article-title":"Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey","volume":"16","author":"D'Erasmo","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124399_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5551\/jat.RV17029","article-title":"Liver transplantation for homozygous familial hypercholesterolemia","volume":"26","author":"Ishigaki","year":"2019","journal-title":"J Atheroscler Thromb"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124399_bib8","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1021\/jacs.5c16971","article-title":"Aromatic ionizable lipids enhance mRNA delivery via coordinating multiple mechanisms","volume":"148","author":"Lin","year":"2026","journal-title":"J. Am. Chem. Soc."},{"issue":"50","key":"10.1016\/j.biomaterials.2026.124399_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202515406","article-title":"Zinc-coordinated lipids: facilitators for enhanced mRNA delivery efficacy","volume":"64","author":"Zhang","year":"2025","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124399_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O'Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124399_bib11","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1021\/acsabm.5c01251","article-title":"Engineered exosomes as programmable nanocarriers for targeted theranostic and translational applications","volume":"12","author":"Patil","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124399_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"22","key":"10.1016\/j.biomaterials.2026.124399_bib13","doi-asserted-by":"crossref","first-page":"12014","DOI":"10.1039\/D0NR00362J","article-title":"Sequential deletion of CD63 identifies topologically distinct scaffolds for surface engineering of exosomes in living human cells","volume":"12","author":"Curley","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2026.124399_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.omtm.2021.04.011","article-title":"Targeting the Apoa1 locus for liver-directed gene therapy","volume":"21","author":"De Giorgi","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124399_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052107","article-title":"The multifaceted role of macrophages in biology and diseases","volume":"26","author":"Brancewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124399_bib16","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"issue":"51","key":"10.1016\/j.biomaterials.2026.124399_bib17","doi-asserted-by":"crossref","first-page":"E10871","DOI":"10.1073\/pnas.1713390114","article-title":"Effect of removing Kupffer cells on nanoparticle tumor delivery","volume":"114","author":"Tavares","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124399_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcmg.2015.11.031","article-title":"Echocardiographic ischemic memory imaging through complement-mediated vascular adhesion of phosphatidylserine-containing microbubbles","volume":"9","author":"Mott","year":"2016","journal-title":"JACC, Cardiovasc. Imaging"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124399_bib19","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCRESAHA.120.316848","article-title":"Apo AI nanoparticles delivered post myocardial infarction moderate inflammation","volume":"127","author":"Richart","year":"2020","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124399_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1194\/jlr.R083121","article-title":"Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function","volume":"59","author":"Shen","year":"2018","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124399_bib21","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1038\/s41467-025-59062-0","article-title":"Apolipoprotein-A1 transports and regulates MMP2 in the blood","volume":"16","author":"Sarker","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124399_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124399_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ultrasmedbio.2025.09.022","article-title":"The bubble-destruction curve obtained using contrast-enhanced ultrasound is useful for assessing liver fibrosis and identifying At-risk MASH in patients with MASLD","volume":"52","author":"Wakui","year":"2026","journal-title":"Ultrasound Med. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124399_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1806444","article-title":"A combined \"eat me\/don't eat me\" strategy based on extracellular vesicles for anticancer nanomedicine","volume":"9","author":"Belhadj","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"7614","key":"10.1016\/j.biomaterials.2026.124399_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124399_bib26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124399_bib27","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.7150\/thno.49874","article-title":"Exosome-based Ldlr gene therapy for familial hypercholesterolemia in a mouse model","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124399_bib28","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41592-022-01658-1","article-title":"An improved imaging system that corrects MS2-induced RNA destabilization","volume":"19","author":"Li","year":"2022","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124399_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00441-003-0698-0","article-title":"Hepatic clearance of sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres","volume":"312","author":"Kindberg","year":"2003","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124399_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1324730","article-title":"Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells","volume":"6","author":"Zhu","year":"2017","journal-title":"J. Extracell. Vesicles"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124399_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12433","article-title":"Extracellular vesicles as human therapeutics: a scoping review of the literature","volume":"13","author":"Fusco","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"Pt 1","key":"10.1016\/j.biomaterials.2026.124399_bib32","article-title":"Hepatocyte-targeted lipid nanoparticle for full-length ATP7B mRNA delivery in Wilson disease","volume":"388","author":"Ma","year":"2025","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124399_bib33","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J. Hepatol."},{"issue":"46","key":"10.1016\/j.biomaterials.2026.124399_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401633","article-title":"Hepatocyte-targeted lipid nanoparticle delivery of HERC2 plasmid controls drug-induced hepatotoxicity by limiting \u03b2-Catenin-Regulated CYP2E1 expression","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124399_bib35","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ultrasmedbio.2022.06.015","article-title":"Utility of sonazoid-enhanced ultrasound for the macroscopic classification of hepatocellular carcinoma: a meta-analysis","volume":"48","author":"Zheng","year":"2022","journal-title":"Ultrasound Med. Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124399_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ultrasmedbio.2017.01.003","article-title":"Pharmacokinetics of perfluorobutane after intra-venous bolus injection of sonazoid in healthy Chinese volunteers","volume":"43","author":"Li","year":"2017","journal-title":"Ultrasound Med. Biol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124399_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70186","article-title":"Efficient scaling up EV-AAVs production via cellular nanoporation for familial hypercholesterolaemia therapy","volume":"14","author":"Yan","year":"2025","journal-title":"J. Extracell. Vesicles"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:10:23Z","timestamp":1785910223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S0142961226004230"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124399","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic \u201ctargeting and blockade\u201d strategy via engineered exosomes and clinical ultrasound contrast agent for hepatocyte-targeted mRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124399"}}